Catalan Translation and Psychometric Validation of the QuickDASH

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorporacion Parc Tauli

About this trial

Patient-reported outcome measures (PROMs) are essential tools for assessing upper extremity disability from the patient's perspective and are increasingly incorporated into routine clinical practice and research. The Quick Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH) is one of the most widely used PROMs in upper limb surgery worldwide. Although the questionnaire has been translated and validated into multiple languages, no officially translated and psychometrically validated Catalan version is currently available. The aim of this study is to translate, cross-culturally adapt and psychometrically validate the Catalan version of the QuickDASH according to internationally accepted recommendations for PROM translation and validation. The project consists of two sequential phases. Phase I comprises forward translation, synthesis, back-translation, expert committee review and cognitive debriefing. Phase II consists of a prospective observational psychometric validation study in Catalan-speaking adults with upper extremity disorders. The resulting instrument is expected to become the official Catalan version of the QuickDASH for use in clinical practice and research.

Eligibility criteria

Qualifiers

Age 18 years or older. Native or fluent Catalan speaker. Diagnosis of an upper extremity musculoskeletal disorder requiring assessment using the QuickDASH questionnaire. Able to read and understand written Catalan. Able and willing to provide written informed consent. Able to complete the questionnaire independently.

Disqualifiers

Cognitive impairment preventing questionnaire completion. Severe neurological or psychiatric disorders interfering with questionnaire interpretation. Inability to read or understand Catalan. Refusal or inability to provide written informed consent. Any other condition that, in the opinion of the investigator, could compromise participation or interpretation of questionnaire results.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Sponsors and collaborators

Corporacion Parc Tauli

Lead sponsor

Federation of European Societies for Surgery of the Hand (FESSH)

Collaborator